Beacon Medæs says it is excited to have launched ‘the next generation’ of medical gas terminal units. The company said: “In line with our ability to stay at the forefront of medical technology, we have produced GEM ‘Shield’ terminal units to better meet our customers’ needs.”
With a curved gas identification ring, the GEM ‘Shield’ ‘not only looks more modern, but also incorporates an anti-microbial additive to help reduce cross-infection’. The anti-microbial additive kills bacterial cells in a number of ways. The additive binds to the cell wall, disrupting growth. The ions interfere with enzyme production, stopping the cell from producing energy, and the additive also interrupts the cell’s DNA, preventing replication. Independent laboratory reports show a reduction of E-coli and MRSA ‘greater than 99 per cent’. A safety taggant enables the user to verify that the unit includes the anti-microbial additive.
“With the anti-microbial additive improving patient safety, our GEM ‘Shield’ terminal units meet needs even beyond what we provided with our trusted GEM 10 installations,” said Andy Tudor, Atlas Copco Medical UK product development manager.
The new GEM ‘Shield’ terminal unit features a ‘modernised’ trim plate that removes dust traps, decreasing crossinfection risk. The fixing screws can be accessed from the front, cutting the exchange time by 15 minutes, for fast, simple routine maintenance.
All GEM ‘Shield’ units can be easily retrofitted onto existing GEM 10 installations.
Beacon Medæs added: “With added patient safety features and improved installation and maintenance, the new GEM ‘Shield’ terminal unit will ensure that the reliable service our products are known for will continue.”
Beacon Medæs Atlas Copco Group Telford Crescent Staveley Derbyshire, S43 3PF
Tel: 01246 561029 Email: andy.tudor@uk.atlascopco.com
